Edwards Lifesciences Europe — Total other segment items increased by 37.8% to $41.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 604.8%, from -$8.30M to $41.90M. Over 3 years (FY 2022 to FY 2025), Europe — Total other segment items shows an upward trend with a 23.8% CAGR.
High volatility or large negative values may signal restructuring activities or unexpected regional charges, while near-zero values indicate stable, standard operations.
This metric aggregates miscellaneous income or expense items specifically attributed to the European segment that are no...
Comparable to 'other segment items' or 'unallocated corporate expenses' reported by diversified global firms.
ew_segment_europe_total_other_segment_items| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$8.73M | -$8.73M | -$8.73M | -$8.73M | -$1.00M | -$1.00M | -$1.00M | -$1.00M | $4.10M | $800.00K | $4.80M | $5.20M | -$8.30M | $15.20M | $28.90M | $30.40M | $41.90M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +88.5% | +0.0% | +0.0% | +0.0% | +510.0% | -80.5% | +500.0% | +8.3% | -259.6% | +283.1% | +90.1% | +5.2% | +37.8% |
| YoY Change | — | — | — | — | +88.5% | +88.5% | +88.5% | +88.5% | +510.0% | +180.0% | +580.0% | +620.0% | -302.4% | >999% | +502.1% | +484.6% | +604.8% |